← Back to Company DatabaseVisit Website
Caris Life Sciences
Comprehensive molecular profiling for precision oncology.
Series C+Irving, TXFounded 2008
About
Caris Life Sciences provides comprehensive molecular profiling services that help oncologists match patients with targeted therapies and clinical trials. Its MI Profile test analyzes DNA, RNA, and proteins from tumor samples to create a molecular blueprint of each patient's cancer. The company also operates a large real-world data network connecting thousands of oncologists.
Total Funding
$830MKey Product
MI Profile comprehensive molecular profilingGeography
North AmericaKey Investors
6 Dimensions CapitalSilver LakeOrbiMed
Focus Areas
DiagnosticsData / AnalyticsTreatment (Therapeutics)
Technology
Genomics / SequencingAI / Machine Learning
Cancer Types
Pan-cancer
Last updated: Feb 4, 2026